Back to Search
Start Over
Economic Evaluation of Interventions to Address Opioid Misuse: A Systematic Review of Methods Used in Simulation Modeling Studies.
- Source :
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2020 Aug; Vol. 23 (8), pp. 1096-1108. Date of Electronic Publication: 2020 Jul 25. - Publication Year :
- 2020
-
Abstract
- Objectives: Several evidence-based interventions exist for people who misuse opioids, but there is limited guidance on optimal intervention selection. Economic evaluations using simulation modeling can guide the allocation of resources and help tackle the opioid crisis. This study reviews methods employed by economic evaluations using computer simulations to investigate the health and economic effects of interventions meant to address opioid misuse.<br />Methods: We conducted a systematic mapping review of studies that used simulation modeling to support the economic evaluation of interventions targeting prevention, treatment, or management of opioid misuse or its direct consequences (ie, overdose). We searched 6 databases and extracted information on study population, interventions, costs, outcomes, and economic analysis and modeling approaches.<br />Results: Eighteen studies met the inclusion criteria. All of the studies considered only one segment of the continuum of care. Of the studies, 13 evaluated medications for opioid use disorder, and 5 evaluated naloxone distribution programs to reduce overdose deaths. Most studies estimated incremental cost per quality-adjusted life-years and used health system and/or societal perspectives. Models were decision trees (n = 4), Markov (n = 10) or semi-Markov models (n = 3), and microsimulations (n = 1). All of the studies assessed parameter uncertainty though deterministic and/or probabilistic sensitivity analysis, 4 conducted formal calibration, only 2 assessed structural uncertainty, and only 1 conducted expected value of information analyses. Only 10 studies conducted validation.<br />Conclusions: Future economic evaluations should consider synergies between interventions and examine combinations of interventions to inform optimal policy response. They should also more consistently conduct model validation and assess the value of further research.<br /> (Copyright © 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Cost-Benefit Analysis
Harm Reduction
Humans
Markov Chains
Models, Econometric
Naloxone economics
Naloxone supply & distribution
Narcotic Antagonists economics
Narcotic Antagonists supply & distribution
Prescription Drug Misuse economics
Prescription Drug Misuse prevention & control
Quality-Adjusted Life Years
Analgesics, Opioid administration & dosage
Opioid-Related Disorders prevention & control
Opioid-Related Disorders therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1524-4733
- Volume :
- 23
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
- Publication Type :
- Academic Journal
- Accession number :
- 32828223
- Full Text :
- https://doi.org/10.1016/j.jval.2020.03.015